Malignant hypertension with thrombotic microangiopathy

11Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

A 49-year-old man with malignant hypertension, acute kidney injury and mental deterioration was referred to our hospital. We initially observed microangiopathic hemolytic anemia, thrombocytopenia and kidney damage, indicating he had thrombotic microangiopathy (TMA). We considered TMA was caused by malignant hypertension and therefore did not start plasma therapy. The French TMA reference center reported that platelet counts and serum creatine levels have high values for predicting severe ADAMTS13 deficiency. The patient fully recovered from his illness after treatment with antihypertensive drugs and intermittent hemodialysis. This case might thus be useful to understand the proper differential diagnosis and treatment of TMA.

Cite

CITATION STYLE

APA

Mitaka, H., Yamada, Y., Hamada, O., Kosaka, S., Fujiwara, N., & Miyakawa, Y. (2016). Malignant hypertension with thrombotic microangiopathy. Internal Medicine, 55(16), 2277–2280. https://doi.org/10.2169/internalmedicine.55.6332

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free